3.20.2 html 134 348 1 false 42 0 false 5 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Balance Sheets (Unaudited) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/StatementBalanceSheetsUnaudited Balance Sheets (Unaudited) Statements 2 false false R3.htm 100020 - Statement - Balance Sheets (Parenthetical) (Unaudited) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/StatementBalanceSheetsParentheticalUnaudited Balance Sheets (Parenthetical) (Unaudited) Statements 3 false false R4.htm 100030 - Statement - Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLossUnaudited Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 100040 - Statement - Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders' Equity (Unaudited) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/StatementStatementsOfChangesInRedeemableConvertiblePreferredStockAndStockholdersEquityUnaudited Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 100050 - Statement - Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders' Equity (Parenthetical) (Unaudited) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/StatementStatementsOfChangesInRedeemableConvertiblePreferredStockAndStockholdersEquityParentheticalUnaudited Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders' Equity (Parenthetical) (Unaudited) Statements 6 false false R7.htm 100060 - Statement - Statements of Cash Flows (Unaudited) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/StatementStatementsOfCashFlowsUnaudited Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 100070 - Statement - Statements of Cash Flows (Parenthetical) (Unaudited) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/StatementStatementsOfCashFlowsParentheticalUnaudited Statements of Cash Flows (Parenthetical) (Unaudited) Statements 8 false false R9.htm 100080 - Disclosure - Nature of the Business Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureNatureOfBusiness Nature of the Business Notes 9 false false R10.htm 100090 - Disclosure - Significant Accounting Policies Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureSignificantAccountingPolicies Significant Accounting Policies Notes 10 false false R11.htm 100100 - Disclosure - License Agreements Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureLicenseAgreements License Agreements Notes 11 false false R12.htm 100110 - Disclosure - Fair Value of Financial Instruments Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 12 false false R13.htm 100120 - Disclosure - Investments Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureInvestments Investments Notes 13 false false R14.htm 100130 - Disclosure - Property and Equipment, Net Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosurePropertyAndEquipmentNet Property and Equipment, Net Notes 14 false false R15.htm 100140 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 15 false false R16.htm 100150 - Disclosure - Redeemable Convertible Preferred Stock and Common Stock Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndCommonStock Redeemable Convertible Preferred Stock and Common Stock Notes 16 false false R17.htm 100160 - Disclosure - Leases Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureLeases Leases Notes 17 false false R18.htm 100170 - Disclosure - Stock-Based Compensation Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 18 false false R19.htm 100180 - Disclosure - Related Party Transactions Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 19 false false R20.htm 100190 - Disclosure - Net Loss Per Share Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureNetLossPerShare Net Loss Per Share Notes 20 false false R21.htm 100200 - Disclosure - Commitments and Contingencies Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 21 false false R22.htm 100210 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureSignificantAccountingPolicies 22 false false R23.htm 100220 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureSignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureSignificantAccountingPolicies 23 false false R24.htm 100230 - Disclosure - Investments (Table) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureInvestmentsTable Investments (Table) Tables http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureInvestments 24 false false R25.htm 100240 - Disclosure - Property and Equipment, Net (Tables) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosurePropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosurePropertyAndEquipmentNet 25 false false R26.htm 100250 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities 26 false false R27.htm 100260 - Disclosure - Leases (Tables) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureLeasesTables Leases (Tables) Tables http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureLeases 27 false false R28.htm 100270 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureStockBasedCompensation 28 false false R29.htm 100280 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureNetLossPerShare 29 false false R30.htm 100290 - Disclosure - Nature of the Business - Additional Information (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails Nature of the Business - Additional Information (Details) Details 30 false false R31.htm 100300 - Disclosure - Significant Accounting Policies - Additional Information (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails Significant Accounting Policies - Additional Information (Details) Details 31 false false R32.htm 100310 - Disclosure - Significant Accounting Policies - Schedule of Estimated Useful Lives of Property and Equipment (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails Significant Accounting Policies - Schedule of Estimated Useful Lives of Property and Equipment (Details) Details 32 false false R33.htm 100320 - Disclosure - Significant Accounting Policies - Schedule of Assets Measured at Fair Value (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfAssetsMeasuredAtFairValueDetails Significant Accounting Policies - Schedule of Assets Measured at Fair Value (Details) Details 33 false false R34.htm 100330 - Disclosure - License Agreements - Additional Information (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetails License Agreements - Additional Information (Details) Details 34 false false R35.htm 100340 - Disclosure - Investments -Schedule of Investments (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureInvestmentsScheduleOfInvestmentsDetails Investments -Schedule of Investments (Details) Details 35 false false R36.htm 100350 - Disclosure - Investments -Schedule of Contractual Maturities of Debt Securities (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfDebtSecuritiesDetails Investments -Schedule of Contractual Maturities of Debt Securities (Details) Details 36 false false R37.htm 100360 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment, Net (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails Property and Equipment, Net - Summary of Property and Equipment, Net (Details) Details 37 false false R38.htm 100370 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) Details 38 false false R39.htm 100380 - Disclosure - Redeemable Convertible Preferred Stock and Common Stock - Additional Information (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndCommonStockAdditionalInformationDetails Redeemable Convertible Preferred Stock and Common Stock - Additional Information (Details) Details 39 false false R40.htm 100390 - Disclosure - Leases - Additional Information (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 40 false false R41.htm 100400 - Disclosure - Leases - Summary of Components of Lease Expense (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureLeasesSummaryOfComponentsOfLeaseExpenseDetails Leases - Summary of Components of Lease Expense (Details) Details 41 false false R42.htm 100410 - Disclosure - Leases - Summary of Maturities of Remaining Operating Lease Liabilities (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureLeasesSummaryOfMaturitiesOfRemainingOperatingLeaseLiabilitiesDetails Leases - Summary of Maturities of Remaining Operating Lease Liabilities (Details) Details 42 false false R43.htm 100420 - Disclosure - Stock-Based Compensation - Additional Information (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails Stock-Based Compensation - Additional Information (Details) Details 43 false false R44.htm 100430 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails Stock-Based Compensation - Summary of Stock Option Activity (Details) Details 44 false false R45.htm 100440 - Disclosure - Stock-Based Compensation - Schedule of Assumptions to Estimate Fair Value of Stock Options Using Black-Scholes Option Pricing Model (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails Stock-Based Compensation - Schedule of Assumptions to Estimate Fair Value of Stock Options Using Black-Scholes Option Pricing Model (Details) Details 45 false false R46.htm 100450 - Disclosure - Stock-Based Compensation - Summary of Non-vested Restricted Stock Award Activity (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureStockBasedCompensationSummaryOfNonVestedRestrictedStockAwardActivityDetails Stock-Based Compensation - Summary of Non-vested Restricted Stock Award Activity (Details) Details 46 false false R47.htm 100460 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details) Details 47 false false R48.htm 100470 - Disclosure - Related Party Transactions - Additional Information (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails Related Party Transactions - Additional Information (Details) Details 48 false false R49.htm 100480 - Disclosure - Net Loss Per Share - Schedule of Potentially Dilutive Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveCommonStockEquivalentsExcludedFromCalculationOfDilutedNetLossPerShareDetails Net Loss Per Share - Schedule of Potentially Dilutive Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share (Details) Details 49 false false R50.htm 100490 - Disclosure - Net Loss Per Share - Schedule of Basic and Diluted Net Loss per Share (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails Net Loss Per Share - Schedule of Basic and Diluted Net Loss per Share (Details) Details 50 false false R51.htm 100500 - Disclosure - Commitments And Contingencies - Additional Information (Details) Sheet http://www.prevailtherapeutics.com/20200930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments And Contingencies - Additional Information (Details) Details 51 false false All Reports Book All Reports prvl-20200930.xml prvl-20200930.xsd prvl-20200930_cal.xml prvl-20200930_def.xml prvl-20200930_lab.xml prvl-20200930_pre.xml http://fasb.org/srt/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true